Isotretinoin therapy and the incidence of acne relapse: a nested case–control study

10.1056/NEJM199507133330206

10.1111/j.1365-2125.2006.02837.x

10.1067/mjd.2001.113717

Harms M, 1986, Dermatologica, 172, 148, 10.1159/000249320

Chivot M, 1990, Dermatologica, 180, 240, 10.1159/000248038

10.1111/j.1365-2133.1993.tb11849.x

Lehucher-Ceyrac D, 1993, Dermatology, 186, 123, 10.1159/000247322

10.1111/j.1365-2133.1993.tb11850.x

10.1111/j.1365-4362.1994.tb01500.x

10.1001/archderm.134.3.376

10.1046/j.1365-4362.1999.00651.x

10.1159/000018130

Al-Mutairi N, 2005, J Drugs Dermatol, 4, 369

10.1111/j.1365-4632.2005.02284.x

10.1159/000090658

Statistiques annuelles, 1997, Regie de l’assurance maladie du Quebec

World Health Organization, 1977, International Classification of Diseases, 9th Revision (ICD-9)

10.1016/0895-4356(94)00234-H

10.1016/S0895-4356(99)00136-5

Levy AR, 1995, Am J Epidemiol, 142, 428, 10.1093/oxfordjournals.aje.a117651

10.1007/s00228-006-0151-x

10.1136/oem.2004.014472

Rothman KJ, 1998, Modern Epidemiology, 2

10.1164/rccm.200210-1231OC

Ho V, 1995, Can J Diagnosis, 12, 1

Tan JK, 2000, Skin Therapy Lett, 6, 1

Madden WS, 2000, J Cutan Med Surg, 4, S2, 10.1177/120347540000400102

10.1001/jama.282.15.1458

10.1067/mjd.2002.120529

Wert S, 2003, Manag Care Interface, 16, 41

Chen K, 2002, J Manag Care Pharm, 8, 272, 10.18553/jmcp.2002.8.4.272